Skip to main content

Table 1 Intra-mouthrinse comparisons of viability of salivary microbiota (%), measured as fluorescence, after treatment with placebo (sterile water), CPC, O-cymen-5-ol, and CPC + O-cymen-5-ol

From: Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial

Time

Mouthrinse

Mean ± SD

95% Conf. Interval

p-value

15 min

Placebo

92.6 ± 18.7

80.03–105.12

0.38

CPC

48.0 ± 13.9

40.98–56.99

< 0.001

O-Cymen-5-ol

79.8 ± 21.0

67.71–91.90

< 0.05

CPC + O-Cymen-5-ol

49.4 ± 14.1

40.98–56.99

< 0.001

30 min

Placebo

96.0 ± 15.6

85.52–106.52

0.64

CPC

58.3 ± 12.9

50.80–65.71

< 0.001

O-Cymen-5-ol

82.7 ± 23.0

69.46–95.98

< 0.05

CPC + O-Cymen-5-ol

54.8 ± 22.9

41.60–68.02

< 0.001

1 h

Placebo

97.7 ± 23.6

81.85–113.59

0.80

CPC

64.9 ± 13.6

57.04–72.75

< 0.001

O-Cymen-5-ol

85.1 ± 21.9

72.45–97.76

0.05

CPC + O-Cymen-5-ol

63.6 ± 21.1

51.42–75.82

< 0.001

2 h

Placebo

99.6 ± 19.3

86.65–112.62

0.98

CPC

69.8 ± 17.0

60.03–79.67

< 0.001

O-Cymen-5-ol

88.0 ± 28.7

71.44–104.55

0.12

CPC + O-Cymen-5-ol

67.5 ± 16.4

58.03–76.94

< 0.001

3 h

Placebo

98.8 ± 19.1

86.00–111.69

0.91

CPC

78.0 ± 14.0

69.92–86.09

< 0.05

O-Cymen-5-ol

90.4 ± 27.5

74.53–106.23

0.22

CPC + O-Cymen-5-ol

67.8 ± 25.7

52.94–82.65

< 0.001

4 h

Placebo

99.8 ± 17.5

87.97–111.52

0.93

CPC

91.0 ± 25.5

76.28–105.74

0.25

O-Cymen-5-ol

92.4 ± 26.7

76.91–107.81

0.34

CPC + O-Cymen-5-ol

80.3 ± 22.8

67.15–93.50

< 0.05

  1. *ANOVA with repeated measures was used to calculate the p-value
  2. SD  Standard deviation